Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM: 5-year follow-up of initially nondiabetic Japanese-American men

Diabetes Care

Volumn 18, Issue 6, 1995, Pages 747-753

  Chen, Kwang Wen ^a   Boyko, Edward J ^a   Bergstrom, Richard W ^a   Leonetti, Donna L ^a   Newell Morris, Laura ^a   Wahl, Patricia W ^a   Fujimoto, Wilfred Y ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; INSULIN;

ADULT; ARTICLE; BODY FAT; BODY MASS; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; RISK FACTOR;

EID: 0029035963     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.18.6.747     Document Type: Article

References (38)

1. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
2. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-368, 1992
3. Porte D Jr: β-cells in type II diabetes mellitus. Diabetes 40:166-180, 1991
4. Mitrakou A, Kelly D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J: Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326:22-29, 1992
5. Efendic S, Östenson C-G: Hormonal responses and future treatment of non-insulin-dependent diabetes mellitus (NIDDM). J Intern Med 234:127-138, 1993
6. Kadowaki T, Miyake Y, Hagura R, Akanuma Y, Kajinuma H, Kuzuya N, Takaku F, Kosaka K: Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 26: 44-49, 1984
7. O'Rahilly SP, Nugent Z, Rudenski AS, Hosker JP, Burnett MA, Darling P, Turner RC: β-cell dysfunction, rather than insulin-insensitivity, is the primary defect in familial type 2 diabetes. Lancet ii:360-364, 1986
8. Charles MA, Fontbonne A, Thibult N, Warnet J-M, Rosselin GE, Eschwege E: Risk factors for NIDDM in white population: Paris prospective study. Diabetes 40: 796-799, 1991
9. Efendic S, Grill V, Luft R, Wajngot A: Low insulin response: a marker of prediabetes. Adv Exp Med Biol 246:167-174, 1988
10. Pimenta W, Mitrakou A, Capani F, Yki-Jârvinen H, Gerich J: β-cell dysfunction with normal insulin sensitivity in glucose tolerant first-degree relatives of Caucasian NIDDM patients (Abstract). Diabetes 41 (Suppl. 1):A143, 1992
11. Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK: Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes 39:283-288, 1990
12. Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Järvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B: Impaired glucose tolerance as a disorder of insulin action: longitudinal and crosssectional studies in Pima Indians. N Engl J Med 318:1217-1225, 1988
13. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR: Role of glucose and insulin resistance in the development of type 2 diabetes mellitus: result of a 25-year follow-up study. Lancet 340:925-929, 1992
14. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113:909-915, 1990
15. Saad MF, Pettitt DJ, Mott DM, Knowler WC, Nelson RG, Bennett PH: Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet i:1356-1359, 1989
16. Sicree RA, Zimmet PZ, King HOM, Coventry JS: Plasma insulin response among Nauruans: prediction of deterioration in glucose tolerance over 6 yr. Diabetes 36: 179-186, 1987
17. Bergstrom RW, Newell-Morris LL, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WY: Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes 39:104-111, 1990
18. Bergstrom RW, Wahl PW, Leonetti DL, Fujimoto WY: Association of fasting glucose levels with a delayed secretion of insulin after oral glucose in subjects with glucose intolerance. J Clin Endocrinol Metab 71:1447-1453, 1990
19. Fujimoto WY, Leonetti DL, Kinyoun JL, Newell-Morris LL, Shuman WP, Stolov WC, Wahl PW: Prevalence of diabetes mellitus and impaired glucose tolerance among second generation JapaneseAmerican men. Diabetes 36:721-729, 1987
20. World Health Organization: WHO Expert Committee on Diabetes Mellitus. Second Report. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646)
21. Dixon WJ, Brown MB, Engelman L, Frane JW, Hill MA, Jenrich RI, Toparek JD: BMDP Statistical Software. Los Angeles, Univ. of California Press, 1981
22. Fujimoto WY: The growing prevalence of non-insulin-dependent diabetes in migrant Asian population and its implications for Asia. Diabetes Res Clin Prac 15: 167-184, 1992
23. Fujimoto WY, Bergstrom RW, Newell-Morris L, Leonetti DL: Nature and nurture in the etiology of type 2 diabetes mellitus in Japanese Americans. Diabetes Metab Rev 5:607-625, 1989
24. Park KS, Rhee BD, Lee KU, Kim SY, Lee HK, Koh CS, Min HK: Intra-abdominal fat is associated with decreased insulin sensitivity in health young men. Metabolism 40:600-603, 1991
25. Hollenbeck CB, Chen N, Chen Y-D I, Reaven GM: Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes 33:460-463, 1984
26. Laakso M: How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959-965, 1993
27. Groop LC, Widén E, Ferrannini E: Insulin resistance and insulin deficiency in pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods. Diabetotogia 36: 1326-1331, 1993
28. Philips DIW, Clark PM, Hales CN, Osmond C: Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabetic Med 11:286-292, 1994
29. Wang SY, Halban PA, Rowe JW: Effects of aging on insulin synthesis and secretion: differential effects on preproinsulin messenger RNA levels, proinsulin biosynthesis, and secretion of newly made and preformed insulin in the rat. J Clin Invest 81: 176-184, 1988
30. Meneilly GS, Tessier D, Dawson K: Alteration in glucose metabolism in elderly patient with diabetes. Diabetes Care 16: 1241-1247, 1993
31. Björntorp P: Abdominal obesity and the development of non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 4:615-622, 1988
32. Jahoor F, Klein S, Wolfe R: Mechanism of regulation of glucose production by lipolysis in humans. Am J Physiol 262:E353-E358, 1992
33. Bouchard C, Després J-P, Mauriége P: Genetic and nongenetic determinants of regional fat distribution. Endocrinol Rev 14: 72-93, 1993
34. Jarrett RJ, Keen H, Fuller JH, McCartney M: Worsening to diabetes in men with impaired glucose tolerance ("borderline diabetes"). Diabetologia 16:25-30, 1979
35. Kadowaki T, Miyake Y, Hagura R, Akanuma Y, Kajinuma H, Kuzuya N, Takaku F, Kosaka K: Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 26: 44-49, 1984
36. Polonsky KS, Rubenstein AH: C-peptide as a measure of the secretion and hepatic extraction of insulin: pitfalls and limitations. Diabetes 33:486-494, 1984
37. Strömblad G, Björntorp P: Reduced hepatic insulin clearance in rats with dietary-induced obesity. Metabolism 35: 323-327, 1986
38. Minaker KL, Rowe JW, Tonino R, Pallotta JA: Influence of age on clearance of insulin in man. Diabetes 31:851-855, 1982